Oral contraceptives and primary liver cancer: temporal trends in three countries.

作者: L ELAINEWAETJEN , D AGRIMES

DOI: 10.1016/S0029-7844(96)00340-7

关键词:

摘要: Objective To determine if vital statistics support a temporal association between the introduction of oral contraceptives (OC) and incidence of, mortality from, primary liver cancer in three countries from different regions world. Methods We used Cancer Incidence Five Continents , volumes I–VI, for data on United States Japan. The Centre Epidemiology Stockholm provided Sweden. obtained U.S. Vital Statistics Japan World Health Annual Sweden Swedish government sources. compiled prevalence OC use all multiple sources, including National Survey Family Growth, Population Council, original articles. Results Despite several hundred million woman-years exposure to OCs, rates among women have not changed substantially States. In Sweden, another country with extensive use, trends paralleled those men. rate is gradually rising Japan, where has been negligible. Conclusion Population-based industrialized very patterns contraceptive provide no measurable effect OCs cancer. Although case-control studies developed suggested an increase risk, such does exist, public health impact appears be

参考文章(20)
Medline A, Wanless Ir, Role of estrogens as promoters of hepatic neoplasia. Laboratory Investigation. ,vol. 46, pp. 313- ,(1982)
John A. Ross, Vincent C. Miller, W. Parker Mauldin, Family Planning and Population: A Compendium of International Statistics ,(1993)
E. Steliarova-Foucher, M. Laversanne, J. Ferlay, D. Forman, S. Antoni, Freddie Ian Bray, C. Gombe Mbalawa, B. Kohler, M. Piñeros, D. H. Brewster, I. Soerjomataram, R. Swaminathan, Cancer Incidence in Five Continents ,(1997)
JULIE R. PALMER, LYNN ROSENBERG, DAVID W. KAUFMAN, M. ELLEN WARSHAUER, PAUL STOLLEY, SAMUEL SHAPIRO, Oral contraceptive use and liver cancer. American Journal of Epidemiology. ,vol. 130, pp. 878- 882 ,(1989) , 10.1093/OXFORDJOURNALS.AJE.A115420
C La Vecchia, E Negri, F Parazzini, Oral contraceptives and primary liver cancer. British Journal of Cancer. ,vol. 59, pp. 460- 461 ,(1989) , 10.1038/BJC.1989.94
J Ranstam, H Olsson, Oral contraceptive use among young women in southern Sweden. Journal of Epidemiology and Community Health. ,vol. 47, pp. 32- 35 ,(1993) , 10.1136/JECH.47.1.32
Ramiro Molina, Luis Martinez, Oriana Salas, Aifredo Dabancens, Tao Yun, Chen Zhi-Heng, Hu Yong-Wei, Alvaro Cuadros, Nubia Aristizabal, Baruch Modan, Elaine Ron, Esther Alfandary, J. G. Mati, Patrick Kenya, Alfred Kungu, D. Gatei, Patrick A. Ibeziako, A. A. Abioye, T. A. Junaid, Patrick U. Aghadiuno, Ruben A. Apelo, Julietta R. De LaCruz, Jose Baens, Benjamin D. Canlas, Suporn Silpisornkosol, Tieng Pardthaisong, Boonlong Sivasomboom, Choti Theetranont, Banpot Boosiri, Supawat Chutivongse, Pramuan Virutamasen, Chansuda Wongsrichanalai, Sermsri Sindhvananda, Suporn Koetsawang, Duangdao Rachawat, Orawan Kiriwat, Nivat Chantarakul, P. P. Anthony, David B. Thomas, Janet L. Stanford, Roberta M. Ray, Elizabeth A. Noonan, Susan Holck, Combined oral contraceptives and liver cancer International Journal of Cancer. ,vol. 43, pp. 254- 259 ,(1989) , 10.1002/IJC.2910430215
JWF Mant, MP Vessey, None, Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives British Journal of Cancer. ,vol. 72, pp. 800- 803 ,(1995) , 10.1038/BJC.1995.415
A Tavani, E Negri, F Parazzini, S Franceschi, C La Vecchia, Female hormone utilisation and risk of hepatocellular carcinoma. British Journal of Cancer. ,vol. 67, pp. 635- 637 ,(1993) , 10.1038/BJC.1993.116
B E Henderson, S Preston-Martin, H A Edmondson, R L Peters, M C Pike, Hepatocellular carcinoma and oral contraceptives British Journal of Cancer. ,vol. 48, pp. 437- 440 ,(1983) , 10.1038/BJC.1983.210